LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
All content for i3 Health Podcast is the property of i3 Health and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
Solving the Ulcerative Colitis Puzzle: How to Navigate the Treatment Journey
i3 Health Podcast
8 minutes 55 seconds
3 months ago
Solving the Ulcerative Colitis Puzzle: How to Navigate the Treatment Journey
For patients with ulcerative colitis, newly developed therapies and tailored treatment strategies have allowed for a more personalized approach to achieving disease control and remission. In this special podcast interview, Dr. Benjamin Cohen, Co-Section Head and Clinical Director of Inflammatory Bowel Diseases at the Cleveland Clinic, offers a behind-the-scenes look at i3 Health’s Virtual Escape Room, which follows Shawn, a 32-year-old man living with ulcerative colitis. Dr. Cohen discusses the greatest challenges in diagnosis and treatment, the importance of staying current with novel therapies and biomarkers, and how this engaging, gamified format not only enhances learning but also translates to improved patient outcomes.
Click here to complete the escape room and claim free CME credit!
https://i3Health.com/uc-escape
i3 Health Podcast
LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T